Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Hemoglobinuria Paroxysmal

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Hemoglobinuria Paroxysmal:

Pubmed Logo
[Air leak syndrome due to graft versus host disease]
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired hemolytic...
5th November, 2009
Arch Bronconeumol. 2009 Jul;45(7):358-9. Epub 2009 Apr 18.
DOI Direct Link
Clinical significance of complement deficiencies.
The complement system is composed of more than 30 serum and membrane-bound...
30th October, 2009
Division of Rheumatology, Allergy and Clinical Immunology, University of Ann N Y Acad Sci. 2009 Sep;1173:108-23.
DOI Direct Link
NKG2D-mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes.
It is considered that a similar immune mechanism acts in the pathogenesis...
9th October, 2009
Department of Haematology/Oncology, Wakayama Medical University, Wakayama, Br J Haematol. 2009 Sep;146(5):538-45. Epub 2009 Jul 6.
DOI Direct Link
Delayed appearance of markers of intravascular haemolysis in a case of paroxysmal cold haemoglobinuria.
The aetiology of haemolytic disease is diverse and the diagnosis often...
9th October, 2009
Department of Clinical Biochemistry, York Hospital, York YO31 8HE, UK. Ann Clin Biochem. 2009 Jul;46(Pt 4):341-3. Epub 2009 May 19.
DOI Direct Link
Use of a FLAER-based WBC assay in the primary screening of PNH clones.
Diagnosis of paroxysmal nocturnal hemoglobinuria (PNH) with flow cytometry...
2nd October, 2009
Laboratory Medicine Program, Toronto General Hospital 11E-416, Toronto, Am J Clin Pathol. 2009 Oct;132(4):564-72.
DOI Direct Link

View more research publications.

Press Releases About Hemoglobinuria Paroxysmal:

BioPortfolio Logo
Reportlinker Adds Immunotherapies and Vaccines for Nontraditional Indications 26th October, 2009 Reportlinker
NEW YORK, Oct. 26 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Immunotherapies and Vaccines for Nontraditional
Teva's 'Patient First' Initiative Highlights Struggle Against High Health Care Costs, Reminds Lawmakers of Reform Goals 20th August, 2009 Teva Pharmaceuticals USA
Real Americans Share Experiences, Common Need for Patient-Centric Reform WASHINGTON, Aug. 20 /PRNewswire-USNewswire/ -- Teva Pharmaceuticals USA, the world's leading generic pharmaceutical company
Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 8th December, 2008 Alexion Pharmaceuticals, Inc.
CHESHIRE, Conn., Dec. 8 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today reported positive results from AEGIS, an open-label registration study examining Soliris(R)
Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting 10th November, 2008 Alexion Pharmaceuticals, Inc.
Initial Physician Experience with Eculizumab in Patients with Other Rare Complement-Mediated Diseases also to be Presented CHESHIRE, Conn., Nov. 10 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals
Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies 2nd September, 2008 Ablation Frontiers, Inc.
CARLSBAD, Calif., Sept. 2 /PRNewswire/ -- Ablation Frontiers, Inc., announced today that two important studies, involving its innovative atrial fibrillation ablation products were presented by Dr.

BioNews Results for Hemoglobinuria Paroxysmal:

RSS Logo
BioPortfolio Logo
Alexion Pharmaceuticals to Present Soliris Data at Annual ASH Meeting
TradingMarkets:  Nov 13 2009 5:28AM Matching: hemoglobinuria paroxysmal
Researchers To Present Additional Data On Soliris(R) (eculizumab) For The Treatment Of Patients With PNH At Th
Medical News Today:  Nov 12 2009 6:19AM Matching: hemoglobinuria paroxysmal
Researchers to Present Additional Data on Soliris (eculizumab) for the Treatment of Patients With PNH at the A
Pharma Live:  Nov 12 2009 12:03AM Matching: hemoglobinuria paroxysmal
Researchers to Present Additional Data on Soliris (eculizumab) for the Treatment of Patients With PNH at the ASH Annual Meeting
Yahoo! Canada:  Nov 11 2009 1:20AM Matching: hemoglobinuria paroxysmal
Researchers to Present Additional Data on Soliris (eculizumab) for the Treatment of Patients With PNH at the
Freshnews.com:  Nov 11 2009 1:49AM Matching: hemoglobinuria paroxysmal
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Hemoglobinuria Paroxysmal Patents:

USPTO Logo
US Patent No.Title
7438906 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
6011138 Gamma-1 anti-human CD23 monoclonal antibodies
6440418 Methods of treating autoimmune diseases with gp39-specific antibodies
6506383 Methods of suppressing immune responses to transplanted tissues and organs with gp39-specific antibodies
6693077 Keratinocyte growth factor-2

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Hemoglobinuria Paroxysmal scientists - we have details of around 237 individuals working on Hemoglobinuria Paroxysmal .


This page has been viewed 293 times
Recent Search Terms used to find this page: Transfusion 2008 48 7 1403-14 | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Hemoglobinuria Paroxysmal across BioPortfolio, or for Hemoglobinuria Paroxysmal Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.